Copyright
©The Author(s) 2025.
World J Gastrointest Surg. Apr 27, 2025; 17(4): 103483
Published online Apr 27, 2025. doi: 10.4240/wjgs.v17.i4.103483
Published online Apr 27, 2025. doi: 10.4240/wjgs.v17.i4.103483
Table 6 Pathological characteristics by analgesic use duration after esophagectomy, n (%)
Pathological characteristic | Short-term analgesic use (n = 149) | Long-term analgesic use (n = 229) | t value or χ² | P value |
TNM stage | 1.90 | 0.17 | ||
I or II stage | 78 (52.35) | 88 (38.43) | ||
III or IV stage | 71 (47.65) | 141 (61.57) | ||
Tumor location | 0.16 | 0.92 | ||
Upper segment | 29 (19.46) | 43 (18.78) | ||
Middle segment | 77 (51.68) | 121 (52.84) | ||
Lower segment | 43 (28.86) | 65 (28.38) | ||
Tumor diameter | 1.40 | 0.24 | ||
< 3 cm | 74 (49.66) | 81 (35.37) | ||
≥ 3 cm | 75 (50.34) | 148 (64.63) | ||
Depth of tumor infiltration | 1.13 | 0.29 | ||
On the muscle layer | 65 (43.62) | 78 (34.06) | ||
Subcutaneous muscle layer | 84 (56.38) | 151 (65.94) | ||
Histological differentiation | 2.74 | 0.26 | ||
Well differentiated | 42 (28.19) | 47 (20.52) | ||
Moderately differentiated | 81 (54.36) | 115 (50.22) | ||
Poorly differentiated | 26 (17.45) | 67 (29.26) | ||
Perineural invasion | 1.49 | 0.22 | ||
No | 124 (83.22) | 162 (70.74) | ||
Yes | 25 (16.78) | 67 (29.26) | ||
Tumor thrombus | 1.22 | 0.27 | ||
No | 125 (83.89) | 176 (76.86) | ||
Yes | 24 (16.11) | 53 (23.14) | ||
Lymph node metastasis | 1.90 | 0.17 | ||
No | 86 (57.72) | 98 (42.79) | ||
Yes | 63 (42.28) | 131 (57.21) |
- Citation: Liu SG, Xu XJ, He M, Zhao JD, Pei L. Perioperative risk factors for prognosis in patients undergoing radical esophagectomy: A retrospective study. World J Gastrointest Surg 2025; 17(4): 103483
- URL: https://www.wjgnet.com/1948-9366/full/v17/i4/103483.htm
- DOI: https://dx.doi.org/10.4240/wjgs.v17.i4.103483